Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03377855 · ClinicalTrials.gov registry record · NA
Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients
A NA study of Opioid Use and Opioid-Related Disorders, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 948
- Enrollment target
- 2
- Study locations
NCT03377855 is a NA study of Opioid Use and Opioid-Related Disorders that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 948 participants, below the 148,251-participant average among 105 other Opioid Use trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03377855, a NA study of Opioid Use and Opioid-Related Disorders, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 948 participants
- Enrollment target
- 2
- Study locations
Study Summary
Risk of long-term opioid dependence increases with initial opioid dose/duration, but despite recent Centers for Disease Control and Prevention (CDC)-endorsed minimum doses for initial opioid prescription, primary care providers are likely to overprescribe. In this quality improvement project, primary care departments at Weill Cornell and the Institute for Family Health (federally qualified health center in New York City) will implement an unobtrusive "nudge" in their electronic prescribing software to promote the CDC-endorsed low doses for all opioids. In the evaluation, we will employ a quasi-experimental design with rigorous interrupted time series analysis methods to assess the effect of the "nudge" on prescribing rates. The analysis will be performed at the provider level, with deidentified physician data and a limited data set (fully deidentified except for date of prescription) of patient-level data.
Conditions Studied
Interventions
- OTHER Default Prescribing Change
Study Locations (2)
New York
- The Institute for Family Health - New York
- Weill Medical College of Cornell University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 948 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03377855
The ClinicalTrials.gov registry entry for NCT03377855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 948 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,251-participant average among 105 other Opioid Use trials with a reported enrollment target (99% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Default Prescribing Change is the first listed.
NCT03377855 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03377855 about?
NCT03377855 is a clinical study titled "Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients". Risk of long-term opioid dependence increases with initial opioid dose/duration, but despite recent Centers for Disease Control and Prevention (CDC)-endorsed minimum doses for initial opioid prescription, primary care providers are likely to overprescribe. In this quality improvement project, primar...
What is the current status of trial NCT03377855?
This trial is currently completed. It is a NA study. The enrollment target is 948 participants. The study started on 2018-02-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03377855 study?
This clinical trial studies the following conditions: Opioid Use, Opioid-Related Disorders, Opioid Abuse, Prescription Drug Abuse and Dependency.
What interventions are being tested in trial NCT03377855?
The interventions under investigation include: Default Prescribing Change (OTHER).
Who is sponsoring clinical trial NCT03377855?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03377855 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.